Essential Human Clec4a/dcir Protein (cle-hm24a) Series [dGE5nuZF]

Essential Human Clec4a/dcir Protein (cle-hm24a) Series [dGE5nuZF]

Introducing the Essential Human Clec4a/dcir Protein (cle-hm24a) Series [dGE5nuZF], a premium protein reagent designed for research applications in immunology and molecular biology. This high-quality protein is derived from human cells, ensuring the highest level of purity and reliability. The CLEC4A/DCIR protein plays a crucial role in the immune response, making it an invaluable tool for studying various diseases and conditions.

• High Purity: Our protein is purified to >95% purity, ensuring consistent and reliable results.
• Stability: The protein is stabilized through advanced biotechnology, maintaining its integrity and functionality.

Product Properties and Specifications

The Essential Human Clec4a/dcir Protein (cle-hm24a) Series [dGE5nuZF] is available in various forms, including lyophilized powder and liquid, to cater to different experimental needs. The protein is supplied in a concentration of 1mg/mL, providing ample material for your research. Each batch undergoes rigorous quality control to ensure that it meets the highest industry standards.

• Applications: Suitable for use in immunoprecipitation, ELISA, Western blot, and other immunological assays.
• Storage: Store at -20°C for long-term stability. Avoid repeated freeze-thaw cycles to maintain protein integrity.

Practical Uses and Target Audience

The Essential Human Clec4a/dcir Protein (cle-hm24a) Series [dGE5nuZF] is an essential tool for researchers in the fields of immunology, oncology, and inflammation. Its applications are vast, including the study of autoimmune diseases, cancer, and infectious diseases. Ideal for both academic and industrial research, this protein reagent can help you advance your research in a wide range of areas.

• Academic Research: Perfect for use in university and research institution laboratories.
• Industrial Applications: Suitable for pharmaceutical and biotechnology companies seeking to develop new treatments and therapies.